These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 12364631

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Cutaneous vasculitis induced by TNF inhibitors: a report of three cases.
    Fujikawa K, Kawakami A, Hayashi T, Iwamoto N, Kawashiri SY, Aramaki T, Ichinose K, Tamai M, Arima K, Kamachi M, Yamasaki S, Nakamura H, Ida H, Origuchi T, Eguchi K.
    Mod Rheumatol; 2010 Feb; 20(1):86-9. PubMed ID: 19812889
    [Abstract] [Full Text] [Related]

  • 24. Rescue of combination therapy failures using infliximab, while maintaining the combination or monotherapy with methotrexate: results of an open trial.
    Ferraccioli GF, Assaloni R, Di Poi E, Gremese E, De Marchi G, Fabris M.
    Rheumatology (Oxford); 2002 Oct; 41(10):1109-12. PubMed ID: 12364628
    [Abstract] [Full Text] [Related]

  • 25. Anti-tumor necrosis factor therapy: 6 year experience of a single center in northern Israel and possible impact of health policy on results.
    Braun-Moscovici Y, Markovits D, Rozin A, Toledano K, Nahir AM, Balbir-Gurman A.
    Isr Med Assoc J; 2008 Apr; 10(4):277-81. PubMed ID: 18548981
    [Abstract] [Full Text] [Related]

  • 26. Modification of pro- and antiinflammatory cytokines and vascular-related molecules by tumor necrosis factor-a blockade in patients with rheumatoid arthritis.
    Macías I, García-Pérez S, Ruiz-Tudela M, Medina F, Chozas N, Girón-González JA.
    J Rheumatol; 2005 Nov; 32(11):2102-8. PubMed ID: 16265686
    [Abstract] [Full Text] [Related]

  • 27. Maintenance of efficacy and safety with subcutaneous golimumab in rheumatoid arthritis patients with low disease activity who previously received TNF inhibitors.
    Wakabayashi H, Inada H, Nishioka Y, Hasegawa M, Sudo A, Nishioka K.
    Clin Rheumatol; 2017 Apr; 36(4):941-946. PubMed ID: 27942977
    [Abstract] [Full Text] [Related]

  • 28. Development of interstitial pneumonia in a rheumatoid arthritis patient treated with infliximab, an anti-tumor necrosis factor alpha-neutralizing antibody.
    Mori S, Imamura F, Kiyofuji C, Sugimoto M.
    Mod Rheumatol; 2006 Apr; 16(4):251-5. PubMed ID: 16906378
    [Abstract] [Full Text] [Related]

  • 29. Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group.
    Lipsky PE, van der Heijde DM, St Clair EW, Furst DE, Breedveld FC, Kalden JR, Smolen JS, Weisman M, Emery P, Feldmann M, Harriman GR, Maini RN, Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group.
    N Engl J Med; 2000 Nov 30; 343(22):1594-602. PubMed ID: 11096166
    [Abstract] [Full Text] [Related]

  • 30. Infliximab: an updated review of its use in Crohn's disease and rheumatoid arthritis.
    Keating GM, Perry CM.
    BioDrugs; 2002 Nov 30; 16(2):111-48. PubMed ID: 11985485
    [Abstract] [Full Text] [Related]

  • 31. Sustained effect after lowering high-dose infliximab in patients with rheumatoid arthritis: a prospective dose titration study.
    van den Bemt BJ, den Broeder AA, Snijders GF, Hekster YA, van Riel PL, Benraad B, Wolbink GJ, van den Hoogen FH.
    Ann Rheum Dis; 2008 Dec 30; 67(12):1697-701. PubMed ID: 18245109
    [Abstract] [Full Text] [Related]

  • 32. [Case report: RAEB in a patient with rheumatoid arthritis treated with methotrexate and infliximab].
    D'Alessandro G, Bianco MR, Politis S, Ferrandina C, Rossi G, Altomare E.
    Reumatismo; 2006 Dec 30; 58(1):59-61. PubMed ID: 16639489
    [Abstract] [Full Text] [Related]

  • 33. Infliximab or rituximab for refractory Wegener's granulomatosis: long-term follow up. A prospective randomised multicentre study on 17 patients.
    de Menthon M, Cohen P, Pagnoux C, Buchler M, Sibilia J, Détrée F, Gayraud M, Khellaf M, Penalba C, Legallicier B, Mouthon L, Guillevin L.
    Clin Exp Rheumatol; 2011 Dec 30; 29(1 Suppl 64):S63-71. PubMed ID: 21586199
    [Abstract] [Full Text] [Related]

  • 34. Infliximab to etanercept switch in patients with spondyloarthropathies and psoriatic arthritis: preliminary data.
    Delaunay C, Farrenq V, Marini-Portugal A, Cohen JD, Chevalier X, Claudepierre P.
    J Rheumatol; 2005 Nov 30; 32(11):2183-5. PubMed ID: 16265699
    [Abstract] [Full Text] [Related]

  • 35. Dose titration using the Disease Activity Score (DAS28) in rheumatoid arthritis patients treated with anti-TNF-alpha.
    Den Broeder AA, Creemers MC, van Gestel AM, van Riel PL.
    Rheumatology (Oxford); 2002 Jun 30; 41(6):638-42. PubMed ID: 12048289
    [Abstract] [Full Text] [Related]

  • 36. Adjunction of rituximab to steroids and immunosuppressants for refractory/relapsing Wegener's granulomatosis: a study on 8 patients.
    Brihaye B, Aouba A, Pagnoux C, Cohen P, Lacassin F, Guillevin L.
    Clin Exp Rheumatol; 2007 Jun 30; 25(1 Suppl 44):S23-7. PubMed ID: 17428359
    [Abstract] [Full Text] [Related]

  • 37. Comparison of the clinical characteristics of vasculitis occurring during anti-tumor necrosis factor treatment or not in rheumatoid arthritis patients. A systematic review of 2707 patients, 18 vasculitis.
    Guignard S, Gossec L, Bandinelli F, Dougados M.
    Clin Exp Rheumatol; 2008 Jun 30; 26(3 Suppl 49):S23-9. PubMed ID: 18799049
    [Abstract] [Full Text] [Related]

  • 38. Prospective study of TNFalpha blockade with adalimumab in ANCA-associated systemic vasculitis with renal involvement.
    Laurino S, Chaudhry A, Booth A, Conte G, Jayne D.
    Nephrol Dial Transplant; 2010 Oct 30; 25(10):3307-14. PubMed ID: 20368305
    [Abstract] [Full Text] [Related]

  • 39. Adverse events and efficacy of TNF-alpha blockade with infliximab in patients with systemic lupus erythematosus: long-term follow-up of 13 patients.
    Aringer M, Houssiau F, Gordon C, Graninger WB, Voll RE, Rath E, Steiner G, Smolen JS.
    Rheumatology (Oxford); 2009 Nov 30; 48(11):1451-4. PubMed ID: 19748965
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.